This person is not registered. Is this you?


Profile Details
David Cunningham
Affiliations:

Royal Marsden Hospital

 
,
Phone: 0044 (0) 207 808 2956
Fax: 0044 (0) 207 808 2556
My Blogs:
My Twitter Hashtags:
@CunninghamFalls
 
Age:
Bio:
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Cancer Biology, Drug Design, Epidemiology, Hepatology, Stem Cells, Surgery, Translational Research
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 4747 / 2941 (What's this?)
Accomplish Score: 38
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 12
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 2 (26 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 2 (12 / 0)
  • OBJECTIVE: Regorafenib demonstrated efficacy in patients with metastatic colorectal cancer (mCRC). ()
  • This study aimed to molecularly characterise colorectal pulmonary metastases (PM) and investigate whether their molecular profiles were concordant with those of the primary tumour. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.